Edmond De Rothschild Holding S.A. Global Blood Therapeutics, Inc. Transaction History

Edmond De Rothschild Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $474,078 - $634,149	-14,605 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $127,489 - $166,482	-3,274 Reduced 18.31%	14,605 $595,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $189,341 - $320,699	5,029 Added 39.14%	17,879 $774,000
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $42,893 - $60,560	813 Added 6.75%	12,850 $709,000
Q2 2020 Aug 07, 2020	SELL	$48.73 - $81.82 $301,053 - $505,483	-6,178 Reduced 33.92%	12,037 $760,000
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $270,137 - $564,620	6,475 Added 55.15%	18,215 $931,000
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $74,308 - $133,104	-1,626 Reduced 12.17%	11,740 $933,000
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $20,316 - $25,943	448 Added 3.47%	13,366 $649,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $679,486 - $817,580	12,918 New	12,918 $679,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.